[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361696-105":59,"doc-detail-361696-en":123},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":116,"head_meta":118,"extra_data":120,"updated_unix":122},105,"en","multiomic-characterization-smad3-diagnostic-prognostic-and-immunological-potential-in-pan-cancer","Multiomic characterization - SMAD3 - diagnostic, prognostic and immunological potential in pan-cancer","","Multiomic analyses were used to evaluate the diagnostic, prognostic, and immunological predictive value of SMAD3 across pan-cancer, with experimental validation in liver hepatocellular carcinoma (LIHC). Bioinformatics integration of TCGA, GTEx, cBioPortal, HPA, UALCAN and related resources assessed differential expression, mutations, immune infiltration, single-cell profiles, DNA methylation, RNA m6A links, and drug sensitivity. SMAD3 was higher in tumors than normal tissues and associated with worse outcomes broadly. SMAD3-related immune checkpoint correlations and single-cell patterns supported its role as a prognostic biomarker and therapeutic target.",{"@graph":69,"@context":115},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multiomic-characterization-smad3-diagnostic-prognostic-and-immunological-potential-in-pan-cancer/361696/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multiomic-characterization-smad3-diagnostic-prognostic-and-immunological-potential-in-pan-cancer/361696.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109],{"name":110,"@type":111,"acceptedAnswer":112},"How is SMAD3 connected to the immune microenvironment?","Question",{"text":113,"@type":114},"The study reports substantial correlations between SMAD3 expression and immune cell infiltration, including significant associations with immune checkpoint genes across diverse cancers.","Answer","https://schema.org",{"og:url":83,"og:type":117,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":119,"canonical":83},"index,follow",{"doc_id":121,"site_id":62},361696,1790210580,{"code":4,"msg":5,"data":124},{"doc_id":121,"user_id":125,"nickname":92,"user_avatar":126,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":127,"file_id":128,"file_url":129,"file_type":130,"file_size":131,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":132,"language":133,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":134,"faqs":135,"seo_title":136,"seo_description":67,"update_tm":137,"read_time":138,"preview_page_count":19,"preview_urls":139},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMultiomic characterization, immunological and prognostic potential ofSMAD3 in pan-cancer and validation in LIHC  \nTao Zhou1, Dan Dan Zhang2, Jiejing jin1, Jinyang Xie1, Jianhua Yu3, Chao Zhu4􀀍 & RongWan1,4􀀍  \nSMAD3, a protein-coding gene, assumes a pivotal role within the transforming growth factorbeta (TGF-β) signaling pathway. Notably, aberrant SMAD3 expression has been linked to various malignancies. Nevertheless, an extensive examination of the comprehensive pan-cancer impact on SMAD3’s diagnostic, prognostic, and immunological predictive utility has yet to be undertaken.  \nBioinformatics methods were employed to systematically investigate the potential carcinogenic impact ofSMAD3. We extensively harnessed data from authoritative sources, includingThe Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), cBioPortal, Human Protein Atlas (HPA), UALCAN, and various other databases. Our study encompassed a comprehensive analysis of the following aspects: differential SMAD3 expression and its association with prognosis across diverse cancer types, gene mutations, immune cell infiltration, single-cell sequencing analysis, DNA methylation patterns, and drug sensitivity profiles. In vitro experiments were conducted with the primary objective of appraising both the expression profile and the precise functional attributes of SMAD3 within the milieu of Liver Hepatocellular Carcinoma (LIHC) . Our findings revealed significant variations in SMAD3 expression between cancerous and adjacent normal tissues. High levels ofSMAD3 expression were consistently associated with unfavorable prognoses across multiple cancer types,. Additionally, our analysis ofSMAD3 methylation patterns in human cancers unveiled a favorable prognosis linked to elevated DNA methylation levels in pan-cancer. Furthermore, we identified positive associations between SMAD3 expression and RNAm6A methylation-related genes in the majority of cancers. Moreover, SMAD3 expression displayed substantial correlations with immune cell infiltration. Notably, immune checkpoint genes exhibited significant associations with SMAD3 expression across diverse cancers. Single-cell sequencing results elucidated the pan-cancer single-cell expression landscape ofSMAD3. Within specific cancer subtypes, SMAD3 expression exhibited a noteworthy positive association with distinctive facets of malignancy. Finally, in our comprehensive analysis of drug sensitivity, we discerned a catalog of prospective therapeutic agents. In our comprehensive analysis across multiple cancer types, we observed a significant disparity in SMAD3 expression compared to normal tissues, and this findings suggest that SMAD3 holds promise as both a prognostic biomarker and a therapeutic target against various cancers. Difference displayed a noteworthy association with patient prognosis.  \nKeywords smad3, Pan-cancer, TGF-β, LIHC, Diagnosis, Prognosis, Immune infiltration  \nCancer ranks as the second leading global cause of mortality, responsible for approximately 14.1 million new  \ncases and 8.2 million annual fatalities1. While recent years have witnessed the emergence of immunotherapy and targeted therapy as novel cancer treatment strategies, their applicability remains limited to a subset of  \n1Jiangxi Key Laboratory of Molecular Medicine, Jiangxi Medical College, The Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang 330006, China. 2Department of General Surgery, Jiangxi Medical College, The Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang 330006, China.  \n3Department of Cardiovascular Medicine, Jiangxi Medical College, The Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang 330006, China. 4Department of Pharmacology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China. 􀀍 email: [czhu@njmu.edu.cn](czhu@njmu.edu.c","cbCaijvev7JmKpVg","https://ap.wps.com/l/cbCaijvev7JmKpVg","pdf",15153411,22,"English","# Background and rationale\n## SMAD3 in TGF-β signaling and cancer\n# Pan-cancer multiomic analysis strategy\n## Data sources and bioinformatics pipeline\n## Differential expression, prognosis, and mutations\n## Immune infiltration and immune checkpoint association\n## Single-cell sequencing and methylation patterns\n## RNA m6A links and drug sensitivity profiling\n# Validation in LIHC and key findings\n## Expression differences between tumor and normal\n## Prognostic relevance across cancer types\n## Therapeutic agent candidates","[{\"question\":\"How is SMAD3 connected to the immune microenvironment?\",\"answer\":\"The study reports substantial correlations between SMAD3 expression and immune cell infiltration, including significant associations with immune checkpoint genes across diverse cancers.\"}]","Multiomic characterization - SMAD3 - diagnostic, prognostic and immunological potential in pan-cancer | PDF",1790145310,55,[140,144,148,152],{"page_no":8,"url":141,"width":142,"height":143},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86baae49c7a90ac8ec88fc84ec632b1f.webp",983,1291,{"page_no":14,"url":145,"width":146,"height":147},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d2b127cc7d1d065eea7ed9bd3bfc48a.webp",982,1290,{"page_no":81,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d5058271540092aee7c8a71b961f35f.webp",981,1289,{"page_no":19,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3c45cb347298627400af9beaf576d32.webp",980,1287]